A detailed history of Quest Partners LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2 shares of STOK stock, worth $26. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2,110 99.91%
Holding current value
$26
Previous $28.5 Million 99.91%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$12.24 - $15.92 $25,801 - $33,559
-2,108 Reduced 99.91%
2 $25,000
Q2 2024

Aug 06, 2024

BUY
$11.03 - $17.52 $23,273 - $36,967
2,110 New
2,110 $28.5 Million

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $522M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.